Lars Noah explores the possibility of a federal preemption, through action of the Food and Drug Administration, of state laws that curtail the use of medications for gender-affirming medical care. Read more here.
Lars Noah explores the possibility of a federal preemption, through action of the Food and Drug Administration, of state laws that curtail the use of medications for gender-affirming medical care. Read more here.